Experimental Therapeutics Program, Spanish National Cancer Research Center, Madrid, Spain.
Cell Cycle. 2011 Jun 15;10(12):1948-55. doi: 10.4161/cc.10.12.15798.
The scaffold protein spinophilin (SPN, PPP1R9B) is a regulatory subunit of phosphatase-1a located at 17q21.31. This region is frequently associated with microsatellite instability and LOH and contains a relatively high density of known tumor suppressor genes (such as BRCA1), putative tumor suppressor genes and several unidentified candidate tumor suppressor genes located distal to BRCA1. Spn is located distal to BRCA1, and we have previously shown that the loss of Spn contributes to human tumorigenesis in the absence of p53 function. In this work, we explore the role of Spn as putative tumor suppressor in in vivo models using genetically modified mice. Spn-knockout mice had decreased lifespan with increased cellular proliferation in tissues such as the mammary ducts and early appearance of tumors, such as lymphoma. Furthermore, the combined loss of Spn and mutant p53 activity led to increased mammary carcinomas, confirming the functional relationship between p53 and Spn. We suggest that Spn may be a novel tumor suppressor located at 17q21.
支架蛋白 spinophilin(SPN,PPP1R9B)是位于 17q21.31 的磷酸酶-1a 的调节亚基。该区域经常与微卫星不稳定性和 LOH 相关,并且包含相对高密度的已知肿瘤抑制基因(如 BRCA1)、假定的肿瘤抑制基因和几个位于 BRCA1 远端的未识别候选肿瘤抑制基因。Spn 位于 BRCA1 远端,我们之前已经表明,在没有 p53 功能的情况下,Spn 的缺失会导致人类肿瘤发生。在这项工作中,我们使用基因修饰小鼠在体内模型中探索 Spn 作为假定的肿瘤抑制因子的作用。Spn 敲除小鼠的寿命缩短,乳腺导管等组织中的细胞增殖增加,并且早期出现淋巴瘤等肿瘤。此外,Spn 和突变型 p53 活性的联合缺失导致乳腺癌增加,证实了 p53 和 Spn 之间的功能关系。我们认为 Spn 可能是位于 17q21 的新型肿瘤抑制因子。